Merger Notification - Announcement according to § 10 Cartel Act
Pfizer Inc.; Baxter Internatioal Inc.; Baxter Healthcare SA; Baxter Aktiengesellschaft; Baxter Deutschland GmbH; Baxter Innovations GmbH
On the following merger was notified at the Federal Competition Authority:
Planned purchase process
Pfizer Inc., the USA, intends to acquire the sole control of Baxters port folio of marketed vaccines by her 100%th subsidiaries Pfizer Ireland Pharmaceuticals und Pfizer Manufacturing Austria GmbH and about a part of Baxters arrangement in Orth, Austria, from Baxter International Inc., Baxter Healthcare SA, Baxter Aktiengeselschaft, Baxter Deutschland GmbH und Baxter Innovations GmbH (Austria). The merger plan concerns the area of Pharmaceutical products and preparations - vaccines.
Industry sector: C - Verarbeitendes Gewerbe/Herstellung von Waren
Deadline for bringing in an application pursuant to § 11(1) Cartel Act will end on 29.09.2014.
Entrepreneurs whose legal or economic interests are affected by the merger can bring in a written statement at the Federal Competition Authority or the Federal Cartel Prosecutor within 14 days from publication date.
Note: The intervening party has no right to a certain treatment of the statement and will not gain a party position.
Non-prohibition of the merger
The Federal Competition Authority and the Federal Cartel Prosecutor have not applied for examination of the merger by the Cartel Court. The standstill obligation (§ 17 (1) Cartel Act) ends with effect from 29.09.2014 .